Impact of Emicizumab on Activated Clotting Time Using the i-STAT Alinity Analyzer

NCT05856903 · clinicaltrials.gov ↗

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia A

Interventions

DIAGNOSTIC_TEST: ACT

Sponsor

University Hospital, Grenoble